Bill > S08380

This bill requires covered entities participating in the 340B drug pricing program (a federal program that allows certain healthcare organizations to purchase prescription drugs at discounted rates) to submit detailed annual reports to the New York State Department of Health beginning April 1, 2026. These reports must comprehensively document their 340B drug activities, including aggregated drug acquisition and payment costs, prescription details broken down by insurance type, the percentage of low-income patients served, operating costs related to drug programs, payments to contract pharmacies and third-party administrators, and the number and location of contract pharmacies. The bill defines key terms such as "340B drugs," "low-income patients," and "contract pharmacies," and mandates that an authorized officer certify the report's accuracy. Additionally, the department is required to publish these reports on a publicly accessible website, thereby increasing transparency about how healthcare organizations use the 340B drug discount program and ensuring that the program's benefits are reaching vulnerable patient populations.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S8380